Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Roflumilast |
Security Level |
|
Mechanism |
Roflumilast: CYP3A4 Inducers (Strong) may decrease the serum concentration of Roflumilast. |
Management |
Roflumilast U.S. prescribing information recommends against combining strong CYP3A4 inducers with roflumilast. The Canadian product monograph makes no such recommendation but notes that such agents may reduce roflumilast therapeutic effects. |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Roflumilast
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Roflumilast Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Roflumilast
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.